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***Dear Editor,***

Wogonin (5, 7-Dihydroxy-8-methoxy flavone) is a traditional naturally occurring flavonoid derived from the root extract of Chinese medicine, named *Scutellaria baicalensis*Georgi. Wogonin contains various biological properties which include allergic diseases, anti-cancer therapy, and anti-inflammatory activities. Wogonin also shows the effects of removing toxins and cleansing the heart (Ancuceanu et al., 2019\[[@R1]\]). The anticancer therapeutic activity of wogonin has been shown by the regulation of different cell signaling pathways, which includes protein kinase B pathway (serine-threonine kinase) and AMP-activated protein kinase pathways (Bei et al., 2020\[[@R2]\]). Wogonin also shows positive therapeutic anticancer effects in breast cancer by inhibiting the 5-LO/BLT2/ERK/IL-8/MMP-9 signaling cascade and establishes a major pharmacological anticancer activity (Bibi et al., 2019\[[@R3]\]). Current biological and pharmacological updates on wogonin have been reviewed (Table 1[(Tab. 1)](#T1){ref-type="fig"}; References in Table 1: Du et al., 2019\[[@R4]\]; Ewendt and Foller, 2019\[[@R5]\]; Fang et al., 2019\[[@R6]\]; Gao et al., 2019\[[@R7]\]; Gharari et al., 2020\[[@R8]\]; Hanioka et al., 2020\[[@R9]\]; Hong et al., 2020\[[@R10]\]; Huang et al., 2020\[[@R11]\]; Jiang et al., 2019\[[@R12]\]; Jiao et al., 2019\[[@R13]\]; Khan and Kamal, 2019\[[@R14]\]\[[@R15]\]; Khushdil et al., 2019\[[@R16]\]; Kim et al., 2019\[[@R17]\]; Kong et al., 2019\[[@R18]\]; Liang et al., 2019\[[@R19]\]; Liau et al., 2019\[[@R20]\]; Luo et al., 2019\[[@R21]\]; Oomen et al., 2020\[[@R22]\]; Tan et al., 2019\[[@R23]\]; Wang and Cui, 2019\[[@R24]\]; Wang et al., 2019\[[@R25]\]\[[@R26]\]; Wang et al., 2020\[[@R27]\]; Xing et al., 2019\[[@R28]\]\[[@R29]\]; Zhang et al., 2019\[[@R30]\]).
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